The National Center for Policy Analysis was not suggesting patients should take half the dose their physician prescribed. Rather we were pointing out that some medications can be prescribed in double-strength doses and the tablet split in half. Often the savings approaches 50%. I wrote a section on this in my policy report “Shopping for Drugs” http://www.ncpa.org/pub/st293?pg=6
One case study focused on the beta blocker Tenormin, which found that the annual cost could be reduced from more than $500 to about $20 by switching to a generic, bulk buying double-strength doses and splitting them in half. Here is the calculations: http://www.ncpa.org/pub/st293?pg=10
Devon Herrick, PhD National Center for Policy Analysisof TX10:54AM April 28, 2009
Just because pills can be cut doesn't mean that the daily dose can be cut in half without reducing drug action to the level of ineffectiveness.
Some drugs do come into the marketplace with recommended doses set too high, but the most recent data suggest that such dose reductions are possible in less than 1 in 4 drugs.
It's a wrong message for the "National Center for Policy Analysis" to be sending to patients. Rendering a medicine ineffective by cutting its dose in half is a bad bargain.
Reader Comments
Back to article
Devon Herrick, PhD National Center for Policy Analysis of TX 10:54AM April 28, 2009
John Urquhart, MD of CA 1:07AM April 28, 2009